Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands

被引:43
作者
Parker, W
Lateef, J
Everett, ML
Platt, JL
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT IMMUNOL,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT PEDIAT,DURHAM,NC 27710
关键词
fine specificity; xenoreactive antibodies; xenotransplantation;
D O I
10.1093/glycob/6.5.499
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transplantation of organs from lower animals such as pigs into humans is prevented by a severe rejection reaction initiated by complement fixing xenoreactive natural antibodies. Most anti-pig xenoreactive natural antibodies in humans are thought to recognize Gal alpha 1-3Gal beta 1-4GlcNAc and are also thought to recognize, albeit less avidly, Gal alpha 1-6Glc. Gal alpha 1-6Glc has been used as a ligand for purification of 'anti-Gal alpha 1-3Gal antibodies' and as a therapeutic or reagent to prevent the binding of these antibodies to porcine organs or cells, We tested the specificity of anti-Gal alpha 1-3Gal IgM for Gal alpha 1-6Glc and related saccharides. Based on inhibition of binding of xenoreactive anti-Gal alpha 1-3Gal IgM to porcine cells by soluble saccharides, anti-Gal alpha 1-3Gal IgM in a human serum was found to consist of a mixture of antibodies which have a similar affinity for Gal alpha 1-3Gal but varying affinities for Gal alpha l-6Glc and other structures, Twenty to 40% of the anti-Galal-3Gal IgM from the population tested did not recognize Gal alpha 1-6Glc. The binding of anti-Gal alpha 1-3Gal IgM to Gal alpha 1-6Glc varied widely from individual to individual, some samples lacking almost entirely anti-Gal alpha 1-3Gal IgM which bound to Gal alpha 1-6Glc.
引用
收藏
页码:499 / 506
页数:8
相关论文
共 34 条
[1]  
BOYDEN SV, 1964, ADV IMMUNOL, V5, P1
[2]  
COLLINS BH, 1995, J IMMUNOL, V154, P5500
[3]  
Collins Braldey H., 1994, Xenotransplantation, V1, P36, DOI 10.1111/j.1399-3089.1994.tb00048.x
[4]  
Cooper D.K.C., 1991, XENOTRANSPLANTATION, P481
[5]  
COOPER DKC, 1988, J HEART TRANSPLANT, V7, P238
[6]  
ECONOMIDOU J, 1967, IMMUNOLOGY, V13, P235
[7]  
FILITTIWURMSER S, 1954, ANN EUGENIC, V18, P183
[8]   THE HUMAN NATURAL ANTI-GAL IGG .3. THE SUBTLETY OF IMMUNE TOLERANCE IN MAN AS DEMONSTRATED BY CROSS-REACTIVITY BETWEEN NATURAL ANTI-GAL AND ANTI-B ANTIBODIES [J].
GALILI, U ;
BUEHLER, J ;
SHOHET, SB ;
MACHER, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) :693-704
[9]   A UNIQUE NATURAL HUMAN-IGG ANTIBODY WITH ANTI-ALPHA-GALACTOSYL SPECIFICITY [J].
GALILI, U ;
RACHMILEWITZ, EA ;
PELEG, A ;
FLECHNER, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (05) :1519-1531
[10]   EVOLUTIONARY RELATIONSHIP BETWEEN THE NATURAL ANTI-GAL ANTIBODY AND THE GAL-ALPHA-1-]3GAL EPITOPE IN PRIMATES [J].
GALILI, U ;
CLARK, MR ;
SHOHET, SB ;
BUEHLER, J ;
MACHER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (05) :1369-1373